MYCOBACTERIUM TUBERCULOSIS MIMIC FOR IMMUNIZATION AND ENHANCEMENT OF BCG VACCINE EFFICACY

• 1. 用于诱导抗结核分枝杆菌免疫反应的重组BCG肺结核疫苗 [P] . 中国专利： CN101939419B . 2016.11.23
• 2. 用于诱导抗结核分枝杆菌免疫反应的重组BCG肺结核疫苗 [P] . 中国专利： CN101939419A . 2011-01-05
• 3. A RECOMBINANT MYCOBACTERIUM BOVIS BCG STRAIN LACKING THE BCG1416C GENE, WITH CAPACITY OF IMPROVED PROTECTION AGAINST TUBERCULOSIS AS A VACCINE CANDIDATE AGAINST THIS DISEASE. [P] . MX2015015918A . 2017-05-18

  机译： 缺少BCG1416C基因的重组牛结核分枝杆菌BCG菌株，对结核病的抵抗力得到改善，可作为预防此病的疫苗。

• 4. RECOMBINANT BCG TUBERCULOSIS VACCINE FOR ELICITING IMMUNE RESPONSES TO MYCOBACTERIUM TUBERCULOSIS [P] . 欧洲知识产权局专利： EP2235163B1 . 2014-01-08

  机译： 重组BCG结核杆菌疫苗，可引起对结核分枝杆菌的免疫反应

• 5. Recombinant BCG tuberculosis vaccine to induce immune responses against Mycobacterium tuberculosis [P] . ES2447032T3 . 2014-03-11

  机译： 重组BCG结核疫苗可诱导针对结核分枝杆菌的免疫反应

• 1. Specific and cross-reactive immune response against Mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from Mycobacterium bovis BCG [J] . Nadine Alvarez, Reinaldo Acevedo, Luis Izquierdo, 亚太热带生物医学杂志（英文版） . 2017,第003期
• 2. Specific and cross-reactive immune response against Mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from Mycobacterium bovis BCG [J] . Nadine, Alvarez, Daymí, 亚太热带生物医学杂志：英文版 . 2017,第003期
• 3. Screening and Assessing 11 Mycobacterium tuberculosis Proteins as Potential Serodiagnostical Markers for Discriminating TB Patients from BCG Vaccinees [J] . Guoqiang Zhang, Lingxia Zhang, Mingcheng Zhang, 基因组蛋白质组与生物信息学报（英文版） . 2009,第003期
• 4. Screening and Assessing 11 Mycobacterium tuberculosis Proteins as Potential Serodiagnostical Markers for Discriminating TB Patients from BCG Vaccinees [J] . Guoqiang Zhang, Lingxia Zhang, Mingcheng Zhang, 基因组蛋白质组与生物信息学报：英文版 . 2009,第003期
• 5. Study on immunogenicity and protective efficacy of a new vaccine expressing Ag85B and MPT83 fusion protein from Mycobacterium tuberculosis [C] . Yufei Jin, Hong Bao, Jing Chang, International Conference on Human Health and Medical Engineering. . 2014
• 6. Comparison of the efficacy of intranasal versus subcutaneous bacillus calmette-guerin (BCG) vaccination against challenge with virulent Mycobacterium tuberculosis. [D] . Uppari, Sridhar. 2012
• 7. Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T cell dependent manner [O] . Juan I. Moliva, Austin P. Hossfeld, Cynthia H. Canan, -1
• 8. Intranasal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances Protection by Parenteral Mycobacterium bovis BCG Immunization against Pulmonary Tuberculosis [O] . Santosuosso, Michael, McCormick, Sarah, Zhang, Xizhong, 2006

• 1. Construction, Expression and Identification of a Recombinant BCG Vaccine Encoding Human Mycobacterium Tuberculosis Heat Shock Protein 65 [J] . 戴五星 ,梁靓 ,高红 . 华中科技大学学报（医学）（英德文版） . 2004,第002期
• 2. CpG7909增强结核分枝杆菌亚单位疫苗免疫保护效果的研究 [C] . 陈火英 ,胡松 ,石春薇 . 第九届全国微生物学青年学者学术研讨会 . 2012
• 3. DMT佐剂增强DNA疫苗免疫原性和抗结核分枝杆菌感染保护效果研究 [A] . 田茂鹏 . 2018